Home

Ajanta Pharma Ltd EPS

Image

Ajanta Pharma Ltd

NSE: AJANTPHARM

EPS

₹ 74.44

Last updated on: Aug 07, 2025

Key Highlights

  • The Earning per Share of Ajanta Pharma Ltd is ₹ 74.44 as of 07 Aug 25 .
  • The earning per share of Ajanta Pharma Ltd changed from ₹ 16.53 to ₹ 20.44 over 9 quarters. This represents a CAGR of 9.90% .

Historical Earning per Share of Ajanta Pharma Ltd

No data available

* All values are in

Company Fundamentals for Ajanta Pharma Ltd

Market Cap

32,680 Cr

EPS

74.4

P/E Ratio (TTM)

35.1

P/B Ratio (TTM)

8.6

Day’s High

2610.2

Day’s Low

2566.75

DTE

0.0

ROE

25.4

52 Week High

3485.75

52 Week Low

2022.05

ROCE

33.1

Market Price of Ajanta Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Ajanta Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Aug 20252615.75
06 Aug 20252542.4
05 Aug 20252636.6
04 Aug 20252637.6
01 Aug 20252694.4
31 Jul 20252750.85
30 Jul 20252800.65
29 Jul 20252822.15
28 Jul 20252771.45
25 Jul 20252781.3

SWOT Analysis Of Ajanta Pharma Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Ajanta Pharma Ltd

Asset Value vs Market Value of Ajanta Pharma Ltd

Market Value

32,680

Asset Value

Value addition

11.4 X

2,628

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Ajanta Pharma Ltd32680
Sun Pharmaceutical Industries Ltd383570
Divis Laboratories Ltd162808
Torrent Pharmaceuticals Ltd121728
Cipla Ltd120468
Mankind Pharma Ltd104912

Historical Market Cap of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Ajanta Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Ajanta Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Ajanta Pharma Ltd News Hub

Ajanta Pharma consolidated net profit rises 10.88% in the December 2024 quarter

Net profit of Ajanta Pharma rose 10.88% to Rs 232.88 crore in the quarter ended December 2024 as aga

Read more

31 Jan 25

Ajanta Pharma Ltd slips for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2759.3, dow

Read more

26 Dec 24

Ajanta Pharma to conduct board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2025. Power

Read more

17 Jan 25

Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2786.7, up 2.5

Read more

03 Feb 25

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

May 2024

Transcript

Oct 2023

Transcript

July 2023

Transcript

May 2023

Transcript

Aug 2022

Transcript

FAQs for EPS of Ajanta Pharma Ltd

What is the EPS of Ajanta Pharma Ltd stock?

The Earnings Per Share (EPS) of Ajanta Pharma Ltd is 74.44. An EPS is the amount of net income attributed to each share of a common stock.

How is Ajanta Pharma Ltd EPS calculated?

The EPS of Ajanta Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Ajanta Pharma Ltd report its EPS?

Ajanta Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Ajanta Pharma Ltd EPS?

Factors that influence the EPS of Ajanta Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Ajanta Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Ajanta Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions